INHIBITION OF LIPID ACCUMULATION IN 3T3-L1 ADIPOCYTES BY MORINDA CITRIFOLIA LINN. LEAF EXTRACTS AND COMMERCIAL HERBAL FORMULAS FOR WEIGHT CONTROL
Keywords:3T3-L1 adipocytes, Adipogenesis, Anti-obesity, Triglyceride, Morinda citrifolia, Herb for weight loss
Objective: To determine the in vitro anti-obesity effects of Morinda citrifolia leaf extract and herbal formulas used for weight loss in Thailand on lipid accumulation in 3T3-L1 adipocytes.
Methods: Differentiated 3T3-L1 adipocytes were treated with 0.1, 0.5 and 1 mg/ml M. citrifolia leaf extract, three herbal formulas (JL-RU, JL-TH, CD-H) and 1, 5 and 10 mg/ml rutin, gallic acid and caffeine. Lipid accumulation determined by measuring Oil Red O staining and triglyceride content measured by a colorimetric method in adipocytes were assayed compared to the control. The effect of test samples on the viability of preadipocytes and differentiated adipocytes were investigated.
Results: Differentiated adipocytes treated with 1 mg/ml M. citrifolia extract moderately inhibited fat accumulation (45.12%) and highly reduced triglyceride content (85.09%). Among the three herbal formulas, JL-TH considerably inhibited fat accumulation (109.17%, 1 mg/ml) and decreased triglyceride content (95.00%, 1 mg/ml) in adipocytes; this was higher than that for CD-H and JL-RU, respectively. The viability of preadipocytes treated with CD-H at 1 mg/ml was slightly decreased while those treated with JL-TH at 0.05-1 mg/ml showed moderately decreased viability in a dose-response manner. For differentiated adipocytes, CD-H at 0.5-1 mg/ml moderately decreased cell viability while JL-TH at 0.05-1 mg/ml caused moderate to high reduction of cell viability in a dose-response relationship.
Conclusion: M. citrifolia extract and three herbal formulas had anti-obesity effects in 3T3-L1 adipocytes, as indicated by a significant reduction in lipid accumulation, triglyceride content, and cell viability. These findings suggest a potential therapeutic approach for the prevention and treatment of obesity.
Glazer G. Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety. Arch Intern Med 2001;161:1814-24.
Kopelman PG. Obesity as a medical problem. Nature 2000;404:635-41.
Leonhardt M, Hrupka B, Langhans W. New approaches in the pharmacological treatment of obesity. Eur J Nutr 1999;38:1-13.
Roh C, Jung U. Nepeta japonica maximowicz extract from natural products inhibits lipid accumulation. J Sci Food Agric 2012;92:2195-9.
Kang JG, Park C. Anti-obesity drugs: a review about their effects and safety. Diabetes Metab J 2012;36:13-25.
Bray GA, Tartaglia LA. Medicinal strategies in the treatment of obesity. Nature 2000;404:672-7.
Goswami P, Khale A, Shah S. Medicinal herbs and obesity: a review. Int J Pharm Sci Rev Res 2011;11:69-74.
Athesh K, Divakar M, Brindha P. Anti-obesity potential of Cyperus rotundus L. aqueous tuber extract in rats fed on high-fat cafeteria diet. Asian J Pharm Clin Res 2014;7:88-92.
Banjare J, Bhalerao S. A survey of marketed ayurvedic/herbal anti-obesity products. Int J Pharm Pharm Sci 2016;8:384-6.
Raja RR, Sreenivasulu M. Morinda citrifolia L.-Phyto-pharmacological perspective review. J Med Herbs Ethnomed 2015;1:68-74.
Saraphanchotiwitthaya A, Sripalakit P. Effect of Morinda citrifolia Linn. leaf extracts on in vitro lipase activity. Chiang Mai J Sci 2014;41:1182-93.
Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983;65:55-63.
Wang YW, Jones PJH. Conjugated linoleic acid and obesity control: efficacy and mechanisms. Int J Obes 2004;28:941-55.
Nakabayashi H, Hashimoto T, Ashida H, Nishiumi S, Kanazawa K. Inhibitory effects of caffeine and its metabolites on intracellular lipid accumulation in murine 3T3-L1 adipocytes. Biofactors 2008;34:293-302.
Kim AR, Yoon BK, Park H, Seok JW, Choi H, Yu JH, et al. Caffeine inhibits adipogenesis through modulation of mitotic clonal expansion and the AKT/GSK3 pathway in 3T3-L1 adipocytes. BMB Rep 2016;49:111-5.
Kersten S. Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep 2001;2:282-6.
Caro JF, Dohm LG, Pories WJ, Sinha MK. Cellular alterations in liver, skeletal muscle, and adipose tissue responsible for insulin resistance in obesity and type II diabetes. Diabetes Metab Rev 1989;5:665-89.
Li KK, Liu CL, Shiu HT, Wong HL, Siu WS, Zhang C, et al. Cocoa tea (Camellia ptilophylla) water extract inhibits adipocyte differentiation in mouse 3T3-L1 preadipocytes. Sci Rep 2016;6:20172.
Zhu HJ, Wang LJ, Wang XQ, Pan H, Li NS, Yang HB, et al. Hormone-sensitive lipase is involved in the action of hydroxy safflor yellow A (HYSA) inhibiting adipogenesis of 3T3-L1cells. Fitoterapia 2014;93:182â€“8.
Birari RB, Bhutani KK. Pancreatic lipase inhibitors from natural sources: Unexplored potential. for Drug Discov2007;12:879-89.
Singh G, Suresh S, Bayineni VK, Kadeppagari RK. Lipase inhibitors from plants and their medical applications. Int J Pharm Pharm Sci 2015;7:1-5.
Yang Y, Yang X, Xu B, Zeng G, Tan J, He X, et al. Chemical constituents of Morus alba L. and their inhibitory effect on 3T3-L1 preadipocyte proliferation and differentiation. Fitoterapia 2014;98:222-7.
Lee H, Kang R, Yoon Y. SH21B, an anti-obesity herbal composition, inhibits fat accumulation in 3T3-L1 adipocytes and high fat diet-induced obese mice through the modulation of the adipogenesis pathway. J Ethnopharmacol 2010;17:709-17.
Lee J, Kim T, Lee J, Lee KJ, Kim H, Yun B, et al. The herbal medicine KBH-1 inhibits fat accumulation in 3T3-L1 adipocytes and reduces high-fat diet-induced obesity through regulation of the AMPK pathway. PLoS One 2015;10:e0142041.
Williamson EM. Synergy and other interactions in phytomedicines. Phytomedicine 2001;8:401-9.
Andersen C, Rayalam S, Della-Fera MA, Baile CA. Phytochemicals and adipogenesis. Biofactors 2010;36:415-22.